Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dattatraya Patil

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Urologic Oncology|April 22, 2025
Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinomaGiacomo Musso, Margaret F Meagher, Kit L Yuen, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
Clinical Genitourinary Cancer|November 24, 2025
Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter AnalysisMai R Dabbas, Melis Guer, Giacomo Musso, et al.
Urology Practice|June 15, 2026
Contemporary Validation of the Renal Cell Carcinoma Inflammatory Score (RISK) for Preoperative Prognostication in Non-Metastatic Renal Cell CarcinomaAdam Braunschweig, Gabriel Ekene Agu, Reza Lahiji, et al.
Clinical Genitourinary Cancer|July 7, 2024
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) RegistryJulian A Cortes, Cesare Saitta, Kit L Yuen, et al.
Clinical Genitourinary Cancer|October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell CarcinomaCesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
The Journal of Urology|September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer TreatmentPeter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Cancers|May 13, 2026
C-Reactive Protein/Albumin Ratio (CAR)-Integrated IMDC Model Improves Risk Stratification in Metastatic Renal Cell CarcinomaAaron I Ahdoot, Cesare Saitta, Giuseppe Garofano, et al.
The Journal of Urology|August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete MetastasectomyAli Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Urologic Oncology|November 20, 2025
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinomaGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Urologic Oncology|April 22, 2025
Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinomaGiacomo Musso, Margaret F Meagher, Kit L Yuen, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
Clinical Genitourinary Cancer|November 24, 2025
Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter AnalysisMai R Dabbas, Melis Guer, Giacomo Musso, et al.
Urology Practice|June 15, 2026
Contemporary Validation of the Renal Cell Carcinoma Inflammatory Score (RISK) for Preoperative Prognostication in Non-Metastatic Renal Cell CarcinomaAdam Braunschweig, Gabriel Ekene Agu, Reza Lahiji, et al.
Clinical Genitourinary Cancer|July 7, 2024
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) RegistryJulian A Cortes, Cesare Saitta, Kit L Yuen, et al.
Clinical Genitourinary Cancer|October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell CarcinomaCesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
The Journal of Urology|September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer TreatmentPeter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Cancers|May 13, 2026
C-Reactive Protein/Albumin Ratio (CAR)-Integrated IMDC Model Improves Risk Stratification in Metastatic Renal Cell CarcinomaAaron I Ahdoot, Cesare Saitta, Giuseppe Garofano, et al.
The Journal of Urology|August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete MetastasectomyAli Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Urologic Oncology|November 20, 2025
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinomaGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
Pageof 15